China, Nov. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multimodal imaging-guided postoperative radiotherapy for prostate cancer based on PSMA-PET/CT and pelvic contrast-enhanced MRI: A bidirectional cohort study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600137130

Registration Time: 2026/11/19

Type: Observational study

Primary Sponsor: Peking University First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=354421

Published by HT Digital Content Services with permission from Health Daily Digest....